US Patent Issued to Genentech on Jan. 20 for "Uses for and article of manufacture including HER2 dimerization inhibitor Pertuzumab" (British Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,867, issued on Jan. 20, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Uses for and article of manufacture including HER2 dimerization inhibitor Pertuzumab" was invented by Graham A. Ross (Welwyn Garden, Great Britain) and Jayantha Ratnayake (Welwyn Garden, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application describes uses for Pertuzumab, a first-in-class HER2 dimerization inhibitor. In particular, the application describes methods for extending progression free survival in a HER2-positive breast cancer patient population; and combining two HER2 antibodies to treat HER2-positive cancer without increas...